首页> 美国卫生研究院文献>other >Binding and neutralization efficiencies of monoclonal antibodies Fab fragments and scFv specific for L1 epitopes on the capsid of infectious HPV particles
【2h】

Binding and neutralization efficiencies of monoclonal antibodies Fab fragments and scFv specific for L1 epitopes on the capsid of infectious HPV particles

机译:感染性HPV颗粒衣壳上L1表位特异的单克隆抗体Fab片段和scFv的结合和中和效率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We compared the neutralization abilities of individual monoclonal antibodies (MAb) of two large panels reactive with L1 epitopes of HPV-11 or HPV-16. Binding titers were compared using both L1-only VLPs and to L1/L2 pseudovirions. While the VLPs were antigenically similar to the pseudovirions, clear differences in the surface exposure of some epitopes were evident with the HPV-16 particles. To determine whether all antibody binding events are equivalent in their neutralizing effect on infectious HPV virions or pseudovirions, the binding and neutralization titers for individual MAbs were used to calculate the relative neutralization efficiency for each antibody. HPV neutralization was achieved by all MAbs capable of strong binding to either linear or conformation-sensitive epitopes on pseudovirus particles. Our data suggest, however, that some L1 epitopes may be more neutralization-sensitive than other surface epitopes, in that successful infection can be blocked by varying degrees of epitope saturation. Additionally, the effective neutralization of virions by several monovalent Fab fragments and single chain variable fragments (scFv) demonstrates that viral neutralization does not require HPV particle aggregation or L1 crosslinking. Identification of capsid protein structures rich in neutralization-sensitive epitopes may aid in the development of improved recombinant vaccines capable of eliciting effective and long-term antibody-mediated protection against multiple HPV types.
机译:我们比较了两个与HPV-11或HPV-16的L1表位反应的大面板的单个单克隆抗体(MAb)的中和能力。使用仅L1的VLP和L1 / L2假病毒颗粒比较结合效价。尽管VLP在抗原性上与假病毒颗粒相似,但HPV-16颗粒在某些表位的表面暴露方面存在明显差异。为了确定所有抗体结合事件在对感染性HPV病毒粒子或假病毒粒子的中和效果上是否相等,使用单个MAb的结合和中和效价计算每种抗体的相对中和效率。 HPV中和是通过所有能够与假病毒颗粒上的线性或构象敏感表位牢固结合的单克隆抗体实现的。但是,我们的数据表明,某些L1表位可能比其他表面表位更敏感,因为成功的感染可以通过不同程度的表位饱和度来阻止。另外,病毒体通过几个单价Fab片段和单链可变片段(scFv)的有效中和表明,病毒中和不需要HPV颗粒聚集或L1交联。鉴定富含中和敏感表位的衣壳蛋白结构可能有助于开发改进的重组疫苗,这些疫苗能够引发针对多种HPV类型的有效且长期的抗体介导的保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号